{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T11:59:14Z","timestamp":1769947154855,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005852","name":"Research Institute for Dental Sciences, Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["936"],"award-info":[{"award-number":["936"]}],"id":[{"id":"10.13039\/501100005852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejphar.2020.173263","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T12:57:05Z","timestamp":1591880225000},"page":"173263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis"],"prefix":"10.1016","volume":"882","author":[{"given":"Sogol","family":"Mazhari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atoosa","family":"Gitiara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaveh","family":"Baghaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behzad","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rozbeh Eslami","family":"Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Asadirad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khojasteh","family":"Joharchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Tokhanbigli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mahmoud","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek J.","family":"\u0141os","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Asadzadeh","family":"Aghdaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Zali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeid","family":"Ghavami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173263_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/art.24186","article-title":"Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis","volume":"60","author":"Akhmetshina","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2020.173263_bib2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1365-2893.2011.01530.x","article-title":"Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development","volume":"18","author":"Alavian","year":"2011","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.ejphar.2020.173263_bib3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.bbamcr.2018.02.007","article-title":"Autophagy modulates transforming growth factor beta 1 induced epithelial to mesenchymal transition in non-small cell lung cancer cells","volume":"1865","author":"Alizadeh","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejphar.2020.173263_bib4","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/MEG.0b013e3283488b00","article-title":"Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells","volume":"23","author":"Amer","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173263_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/ctr.12179","article-title":"Short\u2010term evaluation of autologous transplantation of bone marrow\u2013derived mesenchymal stem cells in patients with cirrhosis: Egyptian study","volume":"27","author":"Amin","year":"2013","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.ejphar.2020.173263_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173263_bib7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.clinbiochem.2007.04.017","article-title":"Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis","volume":"40","author":"Aziz","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejphar.2020.173263_bib8","series-title":"Gastroenterology and hepatology from bed to bench","first-page":"208","article-title":"Isolation, differentiation, and characterization of mesenchymal stem cells from human bone marrow","volume":"10","author":"Baghaei","year":"2017"},{"key":"10.1016\/j.ejphar.2020.173263_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1582-4934.2004.tb00320.x","article-title":"Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy","volume":"8","author":"Baksh","year":"2004","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2020.173263_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/stem.2210","article-title":"Molecular and cellular functions distinguish superior therapeutic efficiency of bone marrow CD 45 cells over mesenchymal stem cells in liver cirrhosis","volume":"34","author":"Baligar","year":"2016","journal-title":"Stem Cell."},{"key":"10.1016\/j.ejphar.2020.173263_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2008.03.002","article-title":"Mesenchymal stem cells: revisiting history, concepts, and assays","volume":"2","author":"Bianco","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejphar.2020.173263_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cytogfr.2015.10.002","article-title":"The PDGF system and its antagonists in liver fibrosis","volume":"28","author":"Borkham-Kamphorst","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejphar.2020.173263_bib13","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.cgh.2017.12.048","article-title":"High prevalence of liver fibrosis among European adults with unknown liver disease: a population-based study","volume":"16","author":"Caballer\u00eda","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173263_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.scr.2008.07.005","article-title":"The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis","volume":"2","author":"Dai","year":"2009","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.ejphar.2020.173263_bib15","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1172\/JCI200419603","article-title":"Imatinib mesylate inhibits the profibrogenic activity of TGF-\u03b2 and prevents bleomycin-mediated lung fibrosis","volume":"114","author":"Daniels","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2020.173263_bib16","article-title":"Mesenchymal stem cells for liver regeneration in liver failure: from experimental models to clinical trials","volume":"2019","author":"de Miguel","year":"2019","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.ejphar.2020.173263_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173263_bib18","series-title":"Imatinib as a Novel Therapeutic Approach for Fibrotic Disorders","author":"Distler","year":"2008"},{"key":"10.1016\/j.ejphar.2020.173263_bib19","doi-asserted-by":"crossref","first-page":"v10","DOI":"10.1093\/rheumatology\/ken276","article-title":"Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosis","volume":"47","author":"Distler","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejphar.2020.173263_bib20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jconrel.2017.09.035","article-title":"Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: a novel strategy with potent efficacy in experimental liver fibrosis","volume":"266","author":"El-Mezayen","year":"2017","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2020.173263_bib21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1468-3083.2011.04398.x","article-title":"Antifibrotic effect after low\u2010dose imatinib mesylate treatment in patients with nephrogenic systemic fibrosis: an open\u2010label non\u2010randomized, uncontrolled clinical trial","volume":"27","author":"Elmholdt","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejphar.2020.173263_bib22","doi-asserted-by":"crossref","first-page":"172616","DOI":"10.1016\/j.ejphar.2019.172616","article-title":"Mechanisms of simvastatin myotoxicity: the role of autophagy flux inhibition","volume":"862","author":"Emami","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173263_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymgme.2008.06.001","article-title":"Cell-based therapies for metabolic liver disease","volume":"95","author":"Enns","year":"2008","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejphar.2020.173263_bib24","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2020.173263_bib25","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1089\/scd.2011.0560","article-title":"Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy","volume":"21","author":"Fouraschen","year":"2012","journal-title":"Stem Cell. Dev."},{"key":"10.1016\/j.ejphar.2020.173263_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.36","article-title":"Autophagy is a regulator of TGF-beta1-induced fibrogenesis in primary human atrial myofibroblasts","volume":"6","author":"Ghavami","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2020.173263_bib27","series-title":"Gastroenterology and hepatology from bed to bench","first-page":"S122","article-title":"Development of experimental fibrotic liver diseases animal model by Carbon Tetracholoride","volume":"10","author":"Gitiara","year":"2017"},{"key":"10.1016\/j.ejphar.2020.173263_bib28","first-page":"142","article-title":"Effect of mesenchymal stem cells on doxorubicin-induced fibrosis","volume":"14","author":"Gorji","year":"2012","journal-title":"Cell J. (Yakhteh)"},{"key":"10.1016\/j.ejphar.2020.173263_bib29","doi-asserted-by":"crossref","first-page":"d793","DOI":"10.2741\/gressner","article-title":"Roles of TGF-beta in hepatic fibrosis","volume":"7","author":"Gressner","year":"2002","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejphar.2020.173263_bib30","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1096\/fj.201600433R","article-title":"Mesenchymal stromal cells and liver fibrosis: a complicated relationship","volume":"30","author":"Haldar","year":"2016","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2020.173263_bib31","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis\u2013a systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"Hemmann","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173263_bib32","first-page":"414","article-title":"Cellular Therapy for Liver Disease","author":"Huebert","year":"2014"},{"key":"10.1016\/j.ejphar.2020.173263_bib33","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1159\/000492558","article-title":"Treatment efficiency of different routes of bone marrow-derived mesenchymal stem cell injection in rat liver fibrosis model","volume":"48","author":"Idriss","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2020.173263_bib34","doi-asserted-by":"crossref","first-page":"881","DOI":"10.6004\/jnccn.2010.0065","article-title":"Using imatinib as neoadjuvant therapy in dermatofibrosarcoma protuberans: potential pluses and minuses","volume":"8","author":"Johnson-Jahangir","year":"2010","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.ejphar.2020.173263_bib35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/DDDT.S124102","article-title":"Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-\u03b2, PDGF-BB, c-Kit and SCF genes","volume":"11","author":"Kadivar","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2020.173263_bib36","doi-asserted-by":"crossref","first-page":"G157","DOI":"10.1152\/ajpgi.90463.2008","article-title":"Transplantation of basic fibroblast growth factor-pretreated adipose tissue-derived stromal cells enhances regression of liver fibrosis in mice","volume":"296","author":"Kamada","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2020.173263_bib37","first-page":"1","article-title":"Protective effects of combined Losartan and Nilotinib on carbon tetrachloride (CCl4)-induced liver fibrosis in rats","author":"Karimi","year":"2018","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2020.173263_bib38","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2020.173263_bib39","first-page":"11","article-title":"Therapeutic effect comparison of hepatocyte-like cells and bone marrow mesenchymal stem cells in acute liver failure of rats","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2020.173263_bib40","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/jcb.20993","article-title":"Differential effects of imatinib on PDGF\u2010induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells","volume":"99","author":"Li","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2020.173263_bib41","article-title":"Challenges and controversies in human mesenchymal stem cell therapy","volume":"2019","author":"Lukomska","year":"2019","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.ejphar.2020.173263_bib42","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3748\/wjg.14.864","article-title":"Stem cells for liver tissue repair: current knowledge and perspectives","volume":"14","author":"Lysy","year":"2008","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1016\/j.ejphar.2020.173263_bib43","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/febs.12163","article-title":"Imatinib as a key inhibitor of the platelet\u2010derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells","volume":"280","author":"Malavaki","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2020.173263_bib44","first-page":"7","article-title":"Therapeutic potential of human umbilical cord derived mesenchymal stem cells on rat model of liver fibrosis","volume":"8","author":"Mansour","year":"2019","journal-title":"Am. J. Stem Cell."},{"key":"10.1016\/j.ejphar.2020.173263_bib45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/liv.13682","article-title":"Liver diseases: a major, neglected global public health problem requiring urgent actions and large\u2010scale screening","volume":"38","author":"Marcellin","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.ejphar.2020.173263_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cld.2015.01.001","article-title":"Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability","volume":"19","author":"McGlynn","year":"2015","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ejphar.2020.173263_bib47","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2014.10.030","article-title":"Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice","volume":"62","author":"Meier","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173263_bib48","first-page":"709","article-title":"Imatinib for refractory chronic graft-versus-host disease with fibrotic features","volume":"114","author":"Olivieri","year":"2009","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.ejphar.2020.173263_bib49","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jhep.2005.10.026","article-title":"Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats","volume":"44","author":"Oyagi","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173263_bib50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mam.2017.11.007","article-title":"The PDGF\/PDGFR pathway as a drug target","volume":"62","author":"Papadopoulos","year":"2018","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ejphar.2020.173263_bib51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0168-8278(98)80318-8","article-title":"Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores: comparison with serum markers","volume":"28","author":"Pilette","year":"1998","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173263_bib52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrgastro.2015.224","article-title":"Liver fibrosis in 2015: crucial steps towards an effective treatment","volume":"13","author":"Poelstra","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173263_bib53","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fphar.2015.00300","article-title":"New insight into the anti-liver fibrosis effect of multitargeted tyrosine kinase inhibitors: from molecular target to clinical trials","volume":"6","author":"Qu","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173263_bib54","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/rme.12.82","article-title":"Stem cell recruitment after injury: lessons for regenerative medicine","volume":"7","author":"Rennert","year":"2012","journal-title":"Regen. Med."},{"key":"10.1016\/j.ejphar.2020.173263_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035639","article-title":"Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrow","volume":"7","author":"Ricciardi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2020.173263_bib56","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.dld.2014.11.012","article-title":"Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV\/HCV co-infection","volume":"47","author":"Sacchi","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ejphar.2020.173263_bib57","article-title":"Imatinib in chronic myeloid leukemia: an overview","volume":"6","author":"Sacha","year":"2014","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.ejphar.2020.173263_bib58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.reth.2016.12.001","article-title":"Phase I clinical study of liver regenerative therapy for cirrhosis by intrahepatic arterial infusion of freshly isolated autologous adipose tissue-derived stromal\/stem (regenerative) cell","volume":"6","author":"Sakai","year":"2017","journal-title":"Regen. Ther."},{"key":"10.1016\/j.ejphar.2020.173263_bib59","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/hep.20452","article-title":"Transplantation of bone marrow cells reduces CCl4\u2010induced liver fibrosis in mice","volume":"40","author":"Sakaida","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2020.173263_bib60","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2020.173263_bib61","first-page":"396","article-title":"Flk1+ mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice","volume":"21","author":"Shi","year":"2005","journal-title":"Chin. J. Biotechnol."},{"key":"10.1016\/j.ejphar.2020.173263_bib62","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2020.173263_bib63","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/1440-1681.12286","article-title":"Tracking anti\u2010fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: a n insight","volume":"41","author":"Shiha","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2020.173263_bib64","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/febs.15069","article-title":"Simvastatin increases temozolomide\u2010induced cell death by targeting the fusion of autophagosomes and lysosomes","volume":"287","author":"Shojaei","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2020.173263_bib65","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173263_bib66","doi-asserted-by":"crossref","first-page":"13622","DOI":"10.1073\/pnas.0501758102","article-title":"The kinase inhibitor imatinib mesylate inhibits TNF-\u03b1 production in vitro and prevents TNF-dependent acute hepatic inflammation","volume":"102","author":"Wolf","year":"2005","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejphar.2020.173263_bib67","doi-asserted-by":"crossref","first-page":"13225","DOI":"10.3748\/wjg.v21.i47.13225","article-title":"Hepatitis B and C virus-induced hepatitis: apoptosis, autophagy, and unfolded protein response","volume":"21","author":"Yeganeh","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2020.173263_bib68","doi-asserted-by":"crossref","first-page":"G907","DOI":"10.1152\/ajpgi.00420.2004","article-title":"Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats","volume":"288","author":"Yoshiji","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2020.173263_bib69","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jfma.2012.12.002","article-title":"Adipose-derived mesenchymal stem cells inhibit activation of hepatic stellate cells in vitro and ameliorate rat liver fibrosis in vivo","volume":"114","author":"Yu","year":"2015","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.ejphar.2020.173263_bib70","doi-asserted-by":"crossref","DOI":"10.4238\/gmr16019352","article-title":"A clinical study of bone mesenchymal stem cells for the treatment of hepatic fibrosis induced by hepatolenticular degeneration","volume":"16","author":"Zhang","year":"2017","journal-title":"Genet. Mol. Res.: GMR"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920303551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920303551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:08:17Z","timestamp":1762142897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920303551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":70,"alternative-id":["S0014299920303551"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173263","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173263"}}